BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21482342)

  • 1. [Pulmonary sarcoidosis developing during treatment with etanercept].
    Kerjouan M; Jouneau S; Lena H; Luraine R; Desrues B; Delaval P
    Rev Mal Respir; 2011 Mar; 28(3):360-4. PubMed ID: 21482342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
    Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.
    Daïen CI; Monnier A; Claudepierre P; Constantin A; Eschard JP; Houvenagel E; Samimi M; Pavy S; Pertuiset E; Toussirot E; Combe B; Morel J;
    Rheumatology (Oxford); 2009 Aug; 48(8):883-6. PubMed ID: 19423648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab.
    Burns AM; Green PJ; Pasternak S
    J Cutan Pathol; 2012 Feb; 39(2):289-93. PubMed ID: 21899592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary sarcoidosis associated with etanercept therapy.
    Farah RE; Shay MD
    Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of sarcoidosis during etanercept therapy.
    Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y
    Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?
    Haroon M; Ryan JG; Harney S
    Clin Rheumatol; 2011 Aug; 30(8):1095-8. PubMed ID: 21380931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
    Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
    Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
    [No Abstract]   [Full Text] [Related]  

  • 9. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sarcoid-like granulomatosis in patients treated with anti-TNFα].
    Petrovici A; Kaiser MJ; Louis R; Nguyen Dang D
    Rev Med Liege; 2016 Mar; 71(3):124-8. PubMed ID: 27311243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.
    Tong D; Manolios N; Howe G; Spencer D
    Intern Med J; 2012 Jan; 42(1):89-94. PubMed ID: 22389903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from an open-label extension study of etanercept in ankylosing spondylitis.
    Davis J; Webb A; Lund S; Sack K
    Arthritis Rheum; 2004 Apr; 51(2):302-4. PubMed ID: 15077279
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V; Mergler S; Pleyer U
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept-induced sarcoidosis in rheumatoid arthritis: FDG PET findings.
    Nakajima R; Abe K; Nakajima A; Nishikawa T; Sakai S
    Clin Nucl Med; 2015 Jan; 40(1):58-61. PubMed ID: 25188646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
    van der Heijde D; Da Silva JC; Dougados M; Geher P; van der Horst-Bruinsma I; Juanola X; Olivieri I; Raeman F; Settas L; Sieper J; Szechinski J; Walker D; Boussuge MP; Wajdula JS; Paolozzi L; Fatenejad S;
    Ann Rheum Dis; 2006 Dec; 65(12):1572-7. PubMed ID: 16968715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.
    Jung JH; Kim JH; Song GG
    Z Rheumatol; 2017 May; 76(4):372-374. PubMed ID: 28124746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis.
    Jethwa H; Mann S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
    Braun J; McHugh N; Singh A; Wajdula JS; Sato R
    Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept].
    Watrin A; Royer M; Legrand E; Gagnadoux F
    Rev Mal Respir; 2014 Mar; 31(3):255-8. PubMed ID: 24680117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.